hydroquinidine has been researched along with Ventricular Fibrillation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andorin, A; Babuty, D; Davy, JM; Defaye, P; Deharo, JC; Delasalle, B; Esnault, S; Fouchard, S; Gourraud, JB; Hermida, JS; Klug, D; le Marec, H; Leenhardt, A; Mabo, P; Mansourati, J; Maury, P; Probst, V; Sacher, F; Sadoul, N | 1 |
| Bagnardi, V; Bellazzi, R; Bloise, R; Kostopoulou, A; Maragna, R; Marino, M; Mazzanti, A; Monteforte, N; Napolitano, C; Pagan, E; Priori, SG; Tibollo, V; Underwood, K; Vacanti, G | 1 |
| Bouzeman, A; Denjoy, I; Extramiana, F; Hermida, JS; Leenhardt, A; Marijon, E; Messali, A; Narayanan, K; Traulle, S | 1 |
| Defaye, P; Jacon, P; Kane, A; Machecourt, J; Mbaye, A | 1 |
| Ben Ameur, Y; Ben Slima, H; Boujnah, MR; Joulak, A; Sdiri, W; Tlili, R | 1 |
| Cauchemez, B; Clerc, J; Denjoy, I; Di Fusco, S; Extramiana, F; Guicheney, P; Hermida, JS; Jarry, G; Leenhardt, A; Milliez, P; Rey, JL | 1 |
1 trial(s) available for hydroquinidine and Ventricular Fibrillation
| Article | Year |
|---|---|
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Cross-Over Studies; Defibrillators, Implantable; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Risk Factors; Time Factors; Ventricular Fibrillation | 2017 |
5 other study(ies) available for hydroquinidine and Ventricular Fibrillation
| Article | Year |
|---|---|
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Heart Rate; Humans; Incidence; Italy; Male; Quinidine; Survival Rate; Ventricular Fibrillation; Young Adult | 2017 |
Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
Topics: Adult; Anti-Arrhythmia Agents; Asymptomatic Diseases; Brugada Syndrome; Defibrillators, Implantable; Electric Countershock; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2014 |
[Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome].
Topics: Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Studies; Heart Conduction System; Humans; Inpatients; Male; Middle Aged; Prostheses and Implants; Quinidine; Syncope; Syndrome; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2012 |
[Early repolarisation with ventricular fibrillation in a young woman].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electrocardiography; Female; Heart Conduction System; Humans; Long-Term Care; Obesity, Morbid; Quinidine; Signal Processing, Computer-Assisted; Syncope; Ventricular Fibrillation; Young Adult | 2013 |
Hydroquinidine therapy in Brugada syndrome.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cohort Studies; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Quinidine; Treatment Outcome; Ventricular Fibrillation | 2004 |